Compare Novavax Inc (NVAX) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Orion Office REIT Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Orion Office REIT Inc trades at $2.65 (market cap $150.60M). The key difference: Novavax Inc is far larger — about 8.6× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.02% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | ONL | |
|---|---|---|
Market Cap | $1.30B | $150.60M |
Sector | Health | Real Estate |
52-Week High | $11.19 | $3.04 |
52-Week Low | $6.22 | $1.93 |
Enterprise Value | $800.50M | $634.25M |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
